BTMPS has been detected in significant quantities in drug samples, with 56% in Los Angeles and 32% in Philadelphia. Many samples contained more BTMPS than fentanyl, suggesting its deliberate addition in production. Possible reasons for its use include serving as a cheap bulking agent or as a light stabilizer for shelf-life extension. Animal studies indicate BTMPS might have harmful effects on the cardiovascular and nervous systems. Reported user effects include blurred vision, nausea, skin irritation, and respiratory issues. Urgent clinical research and surveillance are necessary for understanding its impact.
In Los Angeles, 56 percent of drug samples in September contained BTMPS, while Philadelphia had 32 percent. Many samples show BTMPS presence exceeding fentanyl levels.
BTMPS may be used as a cheap bulking agent for diluting fentanyl, or to utilize its UV-protection feature for prolonging drug shelf life.
Animal studies indicate that BTMPS may pose cardiotoxic and neurological risks, including low blood pressure, muscle weakness, and potential dysfunction in autonomic nervous system.
Clinical reports associate BTMPS use with various side effects including blurred vision, skin irritation, throat irritation, and coughing, highlighting the need for urgent clinical research.
Collection
[
|
...
]